A Study of Multiple Sclerosis Routine Clinical Practice: Impact on Adherence and Clinical Outcomes of Ofatumumab Treated Patients
Clinical trial NCT06897657 · COMPLETED
Trial details
- NCT number
- NCT06897657
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2023-11-06
- Primary completion
- 2024-07-25
- Enrollment
- 155
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.